about
Antimotility agents for chronic diarrhoea in people with HIV/AIDSAntiretroviral regimens for patients with HIV who fail first-line antiretroviral therapyAdverse effects of antiretroviral therapy for HIV infectionThe role of glucocorticoid action in the pathophysiology of the Metabolic SyndromeCerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infectionThe two-year impact of first generation protease inhibitor based antiretroviral therapy (PI-ART) on health-related quality of life.A tonsillar PolyICLC/AT-2 SIV therapeutic vaccine maintains low viremia following antiretroviral therapy cessationDiscovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1A randomised trial of subcutaneous intermittent interleukin-2 without antiretroviral therapy in HIV-infected patients: the UK-Vanguard StudyFangchinoline inhibits human immunodeficiency virus type 1 replication by interfering with gp160 proteolytic processingEvolutionary analysis of human immunodeficiency virus type 1 therapies based on conditionally replicating vectorsCaenorhabditis elegans as a Model System for Studying Drug Induced Mitochondrial ToxicityEstimating the potential pool of HIV-infected deceased organ donors in the United StatesAgeing and inflammation in patients with HIV infection.Ultrasound-assessed perirenal fat is related to increased ophthalmic artery resistance index in HIV-1 patients.Noise-induced hearing loss in mice treated with antiretroviral drugs.Modelling the 3-year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) study.Availability of data on adverse reactions to antiretroviral drugs in medical charts according to the Naranjo algorithm: an example of a Brazilian historical cohort.In vivo assessment of mitochondrial toxicity of metacavir in Rhesus monkeys after three months of intravenous administration.A missing piece in the puzzle: HIV in mature adults in sub-Saharan AfricaImpact of Obliterative Portal Venopathy Associated With Human Immunodeficiency VirusEarly severe morbidity and resource utilization in South African adults on antiretroviral therapy.Effects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection: the STALWART studyEffect of efavirenz on high-density lipoprotein antioxidant properties in HIV-infected patients.Structure-based design, synthesis and biological evaluation of new N-carboxyphenylpyrrole derivatives as HIV fusion inhibitors targeting gp41.Impairment of the activin A autocrine loop by lopinavir reduces self-renewal of distinct human adipose progenitors.Pharmacokinetics of stavudine and didanosine coadministered with nelfinavir in human immunodeficiency virus-exposed neonates.A higher correlation of HCV core antigen with CD4+ T cell counts compared with HCV RNA in HCV/HIV-1 coinfected patientsDrug susceptibility and resistance mutations after first-line failure in resource limited settingsEfavirenz directly modulates the oestrogen receptor and induces breast cancer cell growthAnti-retroviral therapy, insulin resistance and lipodystrophy.Efficacy and safety of darunavir (Prezista(®)) with low-dose ritonavir and other antiretroviral medications in subtype F HIV-1 infected, treatment-experienced subjects in Romania: a post-authorization, open-label, one-cohort, non-interventional, proIn vitro mitochondrial toxicity of metacavir, a new nucleoside reverse transcriptase inhibitor for treatment of hepatitis B virus.Morcellized Omental Transfer for Severe HIV Facial Wasting.Pharmacokinetics and tolerability of the new second-generation nonnucleoside reverse- transcriptase inhibitor KM-023 in healthy subjectsEfavirenz induces neuronal autophagy and mitochondrial alterations.Triptolide inhibits human immunodeficiency virus type 1 replication by promoting proteasomal degradation of Tat proteinOrofacial effects of antiretroviral therapies.Substantial effect of efavirenz monotherapy on bilirubin levels in healthy volunteers.Indices of body fat distribution for assessment of lipodysthrophy in people living with HIV/AIDS.
P2860
Q24240888-A71F6B61-20AC-41F0-BCA8-979A2B8E8523Q24243499-A97DCDA3-FA63-4C5D-B777-B2ECFB164EA3Q24617882-399C60EF-C03D-436E-A646-6F38EF02FA39Q24803696-4BC00D17-06A6-4BE7-9C8B-5C8CE2A011DBQ24810504-7DBFB87E-90D4-4067-8305-8D95E71D372DQ24815914-4533621A-D8BD-4365-9EB0-5C5BEA987F6FQ27319650-D6057C76-D59D-4D89-A8D2-1919074AEA05Q27684242-8D3B9B38-2890-46E3-B9BF-84DFC2607C18Q28469017-C737A3AE-8148-42A5-B08F-AF4773C23868Q28480389-48B5FE7A-C66F-4533-B481-10EBA0686EEBQ28484825-D6765E43-E0D5-41BB-B41C-F01FB3B20F72Q28547224-251674E9-A59A-40D0-B093-B38874779DF4Q28743880-6653BC41-C51E-425A-9480-602CF5E8E57EQ30244296-E58B7B01-233B-429D-96FE-A52D9536FA37Q30480466-E55D1F2B-D4B6-4B70-84BF-87A3FE27A21FQ30489901-6667023B-B10E-470B-A787-934C94F64221Q30762470-B4B7EAC3-D44E-4E6B-8047-E583A7F302C7Q30795747-6F0A29F8-849A-4084-91A1-F4276E34AF0EQ30885827-2C9A16C1-6BAE-4710-8325-CD38A806B952Q33353214-7C05D1C0-4F11-4658-9CAC-8FC22A80424CQ33430799-D74011F1-D5DB-4201-B0BC-8308F664091AQ33518021-95538F96-FD98-4FA4-ADF1-EA9E1B28D6A0Q33534648-A8F665A4-DC1B-4E41-827D-20CE101A6173Q33608017-09E3FF3F-62DC-442B-B876-C9B6FE7B2EBAQ33638192-BF46EEB2-6B93-4DCF-B012-FE0133526522Q33774103-7770E2D1-1393-4BD9-8B3E-091D84538784Q33983697-82B19F5C-88A2-42A1-9CCC-EA2608640EDDQ33999798-8EBF84AB-5888-45C6-A9B3-C3A8EE9A93A7Q34106181-3830A459-51B3-49F3-B340-B20011B31013Q34143084-74EFAD56-D71D-4342-9C31-792EA91E18DEQ34216619-92258CD0-59C3-48A2-BF72-B3828D880FA1Q34249242-FF7216C1-D669-435F-B50F-AF1E0DFC7DEFQ34289964-3924928A-CFFE-4D2A-9563-2874608C5529Q34292154-41934882-5F29-46E7-98D1-D879B7AF8477Q34306474-E0A41B7F-F249-46A9-9017-6CDCB96133C3Q34360731-5E74303B-D1EC-4AD3-A5A9-3A65B025E4C0Q34381967-D51801B7-5113-489F-AA47-CA4BFDB858D2Q34383790-BEE24651-8BDE-43CF-9914-70418DFA50C9Q34404878-47F71E46-F41B-4762-9DDF-5C5384F7F033Q34432001-6BFA1747-0133-43C2-BC10-622FE12F536E
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Adverse effects of antiretroviral therapy.
@ast
Adverse effects of antiretroviral therapy.
@en
Adverse effects of antiretroviral therapy.
@nl
type
label
Adverse effects of antiretroviral therapy.
@ast
Adverse effects of antiretroviral therapy.
@en
Adverse effects of antiretroviral therapy.
@nl
prefLabel
Adverse effects of antiretroviral therapy.
@ast
Adverse effects of antiretroviral therapy.
@en
Adverse effects of antiretroviral therapy.
@nl
P1433
P1476
Adverse effects of antiretroviral therapy.
@en
P2093
P304
P356
10.1016/S0140-6736(00)02854-3
P407
P577
2000-10-01T00:00:00Z